Stock Report

All about this stock under one free report Last Updated: 24-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Arcus Biosciences (RCUS) Key Ratios

Stock Card factsheet share-fund-plan-icon

$18.82

up-down-arrow $-0.54 (-2.79%)

As on 23-Oct-2026 13:43EDT

Market cap

info icon

$2,782 Mln

Revenue (TTM)

info icon

$117 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

7.2

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 141.18 -74.38 -55.34 -1.02 4.71
EBIT 29.60 -4,500.00 -46.92 -21.51 -168.92
Net Profit 28.91 -1,037.50 -47.71 -24.66 -177.30
EPS 29.30 -860.70 -20.88 0.23 -7.57
Book Value -- -- 11.08 -13.41 -5.77
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -167.79-144.95-366.67-139.68-108.14
Net Margin info --13.82-386.32----
Return on equity info -59.30-41.13-82.56-63.26-59.77
Return on Capital info -53.18-36.61---54.81-55.60
Return on Assets info -27.07-18.98-37.56-30.84-25.21
Debt to Equity (x) info ----0.220.180.12

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
--
-54.81
-55.60
-49.12
-30.68
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-82.56

Lower than Peers by 43.35

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
-82.56
-63.26
-59.77
-54.87
-35.64
Peer Median
-39.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-37.56

Lower than Peers by 6.36

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
-37.56
-30.84
-25.21
-25.16
-18.18
Peer Median
-31.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-366.67

Lower than Peers by 294.79

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
-366.67
-139.68
-108.14
-255.56
-235.71
Peer Median
-71.88
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-386.32

Lower than Peers by 303.97

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
-386.32
-142.91
-109.69
-262.39
-238.39
Peer Median
-82.35
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

Lower than Peers by 0.00

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
0.00
--
--
--
--
Peer Median
0.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-55.34

Lower than Peers by 110.34

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
-55.34
-0.04
1.21
0.04
-0.71
Peer Median
55.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-46.92

Lower than Peers by 45.57

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
-46.92
-23.66
6.69
-13.26
-580.00
Peer Median
-1.35
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-47.71

Lower than Peers by 40.63

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
-47.71
-24.73
7.82
-14.98
-603.77
Peer Median
-7.08
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-20.88

Lower than Peers by 34.97

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
-20.88
-0.07
0.25
-0.11
-6.23
Peer Median
14.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-28.62

Lower than Peers by 20.82

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
-28.62
--
--
--
--
Peer Median
-7.80
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.22

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
0.22
0.18
0.12
0.02
0.18
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.03

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
0.03
0.02
0.02
0.02
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

3.82

Lower than Peers by 2.06

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
3.82
4.36
4.50
4.52
5.52
Peer Median
5.88
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

3.82

Lower than Peers by 1.91

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
3.82
--
--
--
6.41
Peer Median
5.72
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-18.65

Lower than Peers by 16.51

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
-18.65
-43.13
-69.75
-149.50
-132.00
Peer Median
-2.14
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

30.77

Higher than Peers by 11.47

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
30.77
6.48
9.69
35.90
38.39
Peer Median
19.30
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.10

Higher than Peers by 0.03

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
0.10
0.22
0.23
0.10
0.08
Peer Median
0.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
--
30.31
47.43
132.68
1,287.87
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
--
--
--
-184.77
-12,189.46
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
--
1,095.75
639.19
19.87
394.74
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
--
--
--
-71.97
-11,296.34
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
--
-7.25
-4.82
-4.67
-5.62
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

7.24

Higher than Peers by 2.73

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
7.24
4.06
2.82
3.10
2.29
Peer Median
4.52
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

3.96

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
3.96
-5.05
-1.66
-2.35
-2.37
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

2,782

Higher than Peers by 2,650

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Arcus Biosciences (RCUS)
2,782
--
--
--
--
Peer Median
132
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...